U.S.: Medicaments Containing Insulin Market 2024

Medicaments Containing Insulin Market Size in the U.S.

After three years of decline, the U.S. medicaments containing insulin market increased by 866% to $X in 2021. Over the period under review, consumption, however, showed a abrupt setback. Medicaments containing insulin consumption peaked at $X in 2012; however, from 2013 to 2021, consumption failed to regain momentum.

Medicaments Containing Insulin Production in the U.S.

In value terms, medicaments containing insulin production reached $X in 2021. In general, production, however, recorded a abrupt decline. Over the period under review, production reached the maximum level at $X in 2012; however, from 2013 to 2021, production stood at a somewhat lower figure.

Medicaments Containing Insulin Exports

Exports from the U.S.

In 2021, after three years of growth, there was significant decline in overseas shipments of medicaments containing insulin but not antibiotics, when their volume decreased by -41.1% to X tons. Overall, exports, however, saw strong growth. The pace of growth appeared the most rapid in 2019 with an increase of 100%. Over the period under review, the exports reached the maximum at X tons in 2020, and then plummeted in the following year.

In value terms, medicaments containing insulin exports reduced notably to $X in 2021. In general, exports saw a abrupt setback. The pace of growth appeared the most rapid in 2018 when exports increased by 81% against the previous year. Over the period under review, the exports attained the peak figure at $X in 2019; however, from 2020 to 2021, the exports remained at a lower figure.

Exports by Country

Denmark (X tons) was the main destination for medicaments containing insulin exports from the United States, with a 97% share of total exports. It was followed by Mexico (X tons), with a 1.8% share of total exports.

From 2012 to 2021, the average annual rate of growth in terms of volume to Denmark totaled +26.0%.

In value terms, Denmark ($X) remains the key foreign market for medicaments containing insulin but not antibiotics exports from the United States, comprising 93% of total exports. The second position in the ranking was taken by Mexico ($X), with a 0.6% share of total exports.

From 2012 to 2021, the average annual rate of growth in terms of value to Denmark totaled +15.6%.

Export Prices by Country

The average medicaments containing insulin export price stood at $X per ton in 2021, reducing by -4.2% against the previous year. Over the period under review, the export price continues to indicate a abrupt downturn. The most prominent rate of growth was recorded in 2016 when the average export price increased by 10%. The export price peaked at $X per ton in 2012; however, from 2013 to 2021, the export prices stood at a somewhat lower figure.

There were significant differences in the average prices for the major overseas markets. In 2021, amid the top suppliers, the country with the highest price was Denmark ($X per ton), while the average price for exports to Mexico stood at $X per ton.

From 2012 to 2021, the most notable rate of growth in terms of prices was recorded for supplies to China (+26.7%), while the prices for the other major destinations experienced mixed trend patterns.

Medicaments Containing Insulin Imports

Imports into the U.S.

In 2021, medicaments containing insulin imports into the United States contracted slightly to X kg, declining by -4.8% against the year before. In general, imports faced a dramatic curtailment. The growth pace was the most rapid in 2015 with an increase of 933% against the previous year. Imports peaked at X tons in 2012; however, from 2013 to 2021, imports stood at a somewhat lower figure.

In value terms, medicaments containing insulin imports dropped slightly to $X in 2021. Over the period under review, imports faced a sharp descent. The pace of growth appeared the most rapid in 2015 when imports increased by 352%. Imports peaked at $X in 2012; however, from 2013 to 2021, imports failed to regain momentum.

Imports by Country

The UK (X kg), Denmark (X kg) and Canada (X kg) were the main suppliers of medicaments containing insulin imports to the United States.

From 2012 to 2021, the most notable rate of growth in terms of purchases, amongst the main suppliers, was attained by Canada (with a CAGR of +10.4%), while imports for the other leaders experienced a decline.

In value terms, the UK ($X) constituted the largest supplier of medicaments containing insulin but not antibiotics to the United States, comprising 74% of total imports. The second position in the ranking was taken by Denmark ($X), with a 16% share of total imports.

From 2012 to 2021, the average annual rate of growth in terms of value from the UK stood at -16.5%. The remaining supplying countries recorded the following average annual rates of imports growth: Denmark (-50.5% per year) and Canada (+4.1% per year).

Import Prices by Country

The average medicaments containing insulin import price stood at $X per ton in 2021, growing by 2.7% against the previous year. Over the period under review, the import price, however, faced a abrupt setback. The most prominent rate of growth was recorded in 2019 an increase of 114% against the previous year. Over the period under review, average import prices hit record highs at $X per ton in 2013; however, from 2014 to 2021, import prices stood at a somewhat lower figure.

There were significant differences in the average prices amongst the major supplying countries. In 2021, amid the top importers, the country with the highest price was Canada ($X per ton), while the price for Denmark ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by the UK (+17.5%), while the prices for the other major suppliers experienced a decline.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :